Table 1. Comparison by gender.
| Women N = 31 | Men N = 29 | P | |
|---|---|---|---|
| Age, years | 59 [57–64] | 59 [55–63] | 0.389 |
| Cardiovascular risk factors | |||
| Smoking habit, n (%) | 2 (7%) | 7 (24%) | 0.076 |
| Hypertension, n (%) | 13 (42%) | 19 (66%) | 0.077 |
| Dyslipidemia, n (%) | 12 (39%) | 10 (35%) | 0.793 |
| Anthropometric mesures | |||
| BMI, kg/m2 | 33 [32–35] | 35 [32–37] | 0.149 |
| Waist circumference, cm | 103 [97–106] | 120 [109–124] | <0.001 |
| Body composition | |||
| Fat mass, % | 51 [47–54] | 41 [35–44] | <0.001 |
| Fat free mass, % | 49 [46–53] | 59 [56–65] | <0.001 |
| Fat/free fat ratio | 1.03 [0.88–1.15] | 0.71 [0.54–0.80] | <0.001 |
| Fat mass index, kg/m2 | 16.3 [15.3–18.9] | 14.6 [10.9–16.7] | <0.001 |
| Fat-free mass index, kg/m2 | 16.6 [15.8–17.6] | 21.0 [19.2–21.8] | <0.001 |
| Vital signs | |||
| Systolic blood pressure, mmHg | 110 [105–120] | 120 [113–130] | 0.010 |
| Diastolic blood pressure, mmHg | 70 [60–70] | 70 [70–80] | 0.008 |
| Heart rate, beat/min | 60 [56–68] | 62 [55–69] | 0.930 |
| Creatinine, mg/dl | 0.74 [0.65–0.79] | 1.00 [0.85–1.07] | <0.001 |
| Lipid profile | |||
| Total cholesterol, mg/dl | 214 [188–241] | 190 [180–216] | 0.028 |
| HDL cholesterol, mg/dl | 56 [51–65] | 44 [38–51] | <0.001 |
| LDL cholesterol, mg/dl | 133 [113–150] | 120 [108–144] | 0.204 |
| Triglycerides, mg/dl | 100 [81–121] | 110 [84–145] | 0.391 |
| Glucose profile | |||
| Glucose, mg/dl | 95 [90–110] | 98 [95–107] | 0.662 |
| Glycated Hemoglobin, mmol/mol | 37 [35–41] | 36 [35–39] | 0.334 |
| Insulin, μU/ml | 11.8 [7.8–18.8] | 13.8 [10.1–21.0] | 0.325 |
| HOMA Index | 2.53 [1.80–5.11] | 3.41 [2.37–5.53] | 0.348 |
| HOMA index class | 0.366 | ||
| <2.5 | 14 (45%) | 8 (28%) | |
| 2.5–3.8 | 6 (19%) | 7 (24%) | |
| >3.8 | 11 (36%) | 14 (48%) | |
| AGE score | 2.23 [2.10–2.50] | 2.25 [2.05–2.60] | 0.918 |
| FINDRISC | 14 [12–17] | 14 [12–17] | 0.817 |
| FLI | 64 [55–77] | 92 [79–94] | <0.001 |
| Irisin, ng/ml | 161 [105–198] | 83 [33–115] | <0.001 |
Data are expressed as number (%) and median and interquartiles [I-III].
AGE, Advanced Glycation End-products; BMI, Body Mass Index; FLI, Fatty Liver Index; FINDRISC, Finnish Diabetes Risk Score; HDL, High-Density Lipoprotein; LDL, Low-Density Lipoprotein; HOMA, Homeostasis Model Assessment.